33.77

2.06% -0.71

After Hours: 33.71 -0.06 -0.18%

Neurogene Inc (NGNE)

Overview News Price History Discussions Forecast

Neurogene Inc stock is currently priced at $33.77, with a 24-hour trading volume of 61,261. It has seen a -2.06% decreased in the last 24 hours and a -27.81% declined in the past month. The chart indicates a potential bearish trend, as the stock is below the $34.28 pivot point. If it approaches the $33.47 support level, significant changes may occur.

Previous Close:

$34.48

Open:

$34.13

24h Volume:

61,261

Market Cap:

$434.05M

Revenue:

Net Income/Loss:

P/E Ratio:

EPS:

Net Cash Flow:

1W Performance:

+11.71%

1M Performance:

-27.81%

6M Performance:

+0.00%

1Y Performance:

+0.00%

1D Range:

$33.66

$35.24

52W Range:

$15.19

$53.00

Neurogene Inc Stock (NGNE) Company Profile

Name

Neurogene Inc

Sector

Healthcare (1189)

Industry

Biotechnology (685)

Phone

(877) 237-5020

Address

535 W 24th Street, 5th Floor, New York

Employee

Twitter

Next Earnings Date

2024-05-06

Latest SEC Filings

NGNE's Discussions on Twitter

Neurogene Inc Stock (NGNE) Financials Data

There is no financial data for Neurogene Inc (NGNE). Check out other stocks for more information.

Neurogene Inc. develops life-changing genetic medicines for patients and their families affected by neurological diseases. Its product candidate includes NGN-401, an investigational AAV9 gene therapy for the treatment of Rett syndrome; and NGN-101 to treat neuronal ceroid lipofuscinosis subtype 5 batten disease. The company is headquartered in New York, New York.